Skip to main content
. 2020 May 6;9(6):1468–1478. doi: 10.1021/acssynbio.0c00130

Figure 1.

Figure 1

(a) MALDI-TOF MS data of CS5 before (blue) and after (red) treatment with CDAP and hypothetical structure of CS5. (b) SDS-Tricine gel of CS5 coexpressed with NisBTC or NisT before (&) and after (#) streptavidin column purification. (c) LC-MS/MS data of CS5(13–20). The observed fragments demonstrate that the cyclic strep ligand was formed.